1. A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan 
Yi-Chun Chen, Yu-Chieh Su, Chung-Yi Li, Chia-Pin Wu, Moon-Sing Lee 
Kidney International 
Volume 87, Issue 5, Pages (May 2015)
DOI: /ki
Copyright © 2015 International Society of Nephrology Terms and Conditions

2. Figure 1
Cumulative incidence of end-stage renal disease (ESRD) in the hepatitis B virus (HBV; dash line) and non-HBV (solid line) cohorts. Data were compiled after adjustment for competing mortality.
Kidney International  , DOI: ( /ki )
Copyright © 2015 International Society of Nephrology Terms and Conditions

3. Figure 2
Cumulative incidence of end-stage renal disease (ESRD) according to men aged <60 (black line) versus ≥60 years (red line) in the hepatitis B virus (HBV; dash line) and non-HBV (solid line) cohorts.
Kidney International  , DOI: ( /ki )
Copyright © 2015 International Society of Nephrology Terms and Conditions

4. Figure 3
Cumulative incidence of end-stage renal disease (ESRD) according to women aged <60 (black line) versus ≥60 years (red line) in the hepatitis B virus (HBV; dash line) and non-HBV (solid line) cohorts.
Kidney International  , DOI: ( /ki )
Copyright © 2015 International Society of Nephrology Terms and Conditions